Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Retraction for Venkataraman et al., Selective cell death mediated by small conditional RNAs.

Dirks RM, Ueda CT, Pierce NA.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):384. doi: 10.1073/pnas.1221212110. Epub 2012 Dec 17. No abstract available.

2.

Selective cell death mediated by small conditional RNAs.

Venkataraman S, Dirks RM, Ueda CT, Pierce NA.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16777-82. doi: 10.1073/pnas.1006377107. Epub 2010 Sep 7. Retraction in: Dirks RM, Ueda CT, Pierce NA. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):384.

3.

Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms.

Hauck WW, Shah VP, Shaw SW, Ueda CT.

Pharm Res. 2007 Nov;24(11):2018-24. Epub 2007 May 26.

PMID:
17530388
4.
6.

Factors affecting pharmacists' selection of rural or urban practice sites in Nebraska.

Scott DM, Neary TJ, Thilliander T, Ueda CT.

Am J Hosp Pharm. 1992 Aug;49(8):1941-5. Erratum in: Am J Hosp Pharm 1992 Oct;49(10):2444.

PMID:
1442837
7.

Comparative bioavailability characteristics of commercial quinidine polygalacturonate and sulfate tablets.

Dahl JR, Ueda CT, Meyers DG, Wulf BG.

DICP. 1990 Jul-Aug;24(7-8):685-8.

PMID:
2375136
8.

Phenytoin disposition in the pregnant rat. Dose-dependent studies and salicylate effects.

Cleveland PA, Ueda CT.

Drug Metab Dispos. 1990 Jan-Feb;18(1):72-9.

PMID:
1970781
9.

Further observations on the disposition characteristics of salicylic acid in analbuminemic rats.

Hirate J, Kato Y, Horikoshi I, Nagase S, Ueda CT.

Biopharm Drug Dispos. 1989 May-Jun;10(3):299-309.

PMID:
2720133
10.

Radiolabeled 9- or 10-monoiodostearic acid and 9- or 10-monoiodostearyl carnitine--I. Synthesis and purification.

Reed KW, Ueda CT, Murray WJ, Augustine SC.

Int J Rad Appl Instrum A. 1989;40(1):27-31.

PMID:
2540120
11.
12.

Amiodarone pharmacokinetics. II. Disposition kinetics following subchronic administration in rats.

Weir SJ, Ueda CT.

Biopharm Drug Dispos. 1987 Sep-Oct;8(5):449-60.

PMID:
3663881
13.

Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.

Weir SJ, Ueda CT.

J Pharmacokinet Biopharm. 1986 Dec;14(6):601-13.

PMID:
3820092
14.

Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets.

Weir SJ, Myers VA, Bengtson KD, Ueda CT.

Am J Hosp Pharm. 1985 Dec;42(12):2679-83.

PMID:
4083289
15.

Effects of ibuprofen on the disposition kinetics of phenytoin in pregnant rats.

Cleveland PA, Ueda CT.

Biopharm Drug Dispos. 1985 Apr-Jun;6(2):167-76.

PMID:
4005395
17.

Effect of column temperature and eluent flow rate on the high performance liquid chromatographic analysis of cyclosporin a and d.

Mereish KA, Ueda CT.

Pharm Res. 1984 Nov;1(6):245-9. doi: 10.1023/A:1016337817145.

PMID:
24277356
18.

Serum disopyramide concentrations and suppression of ventricular premature contractions.

Ueda CT, Dzindzio BS, Vosik WM.

Clin Pharmacol Ther. 1984 Sep;36(3):326-36.

PMID:
6467792
19.

Effect of antacid on the bioavailabiity of lithium carbonate.

Goode DL, Newton DW, Ueda CT, Wilson JE, Wulf BG, Kafonek D.

Clin Pharm. 1984 May-Jun;3(3):284-7.

PMID:
6428800
20.

Effects of salicylate on maternal and fetal phenytoin pharmacokinetics in rats.

Cleveland PA, Ueda CT.

Drug Metab Dispos. 1984 May-Jun;12(3):285-90.

PMID:
6145554
21.

Apparent dose-dependent oral absorption of cyclosporin A in rats.

Ueda CT, Lemaire M, Gsell G, Misslin P, Nussbaumer K.

Biopharm Drug Dispos. 1984 Apr-Jun;5(2):141-51.

PMID:
6743782
22.
23.

Stability of nitroglycerin in intravenous admixtures.

Klamerus KJ, Ueda CT, Newton DW.

Am J Hosp Pharm. 1984 Feb;41(2):303-5.

PMID:
6422753
24.

Effect of caffeine on the oral absorption and disposition of quinidine.

Zeller FP, Ueda CT, Wulf BG, Meyers DG.

Clin Pharm. 1984 Jan-Feb;3(1):72-5.

PMID:
6697677
25.
26.

Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.

Ueda CT, Lemaire M, Gsell G, Nussbaumer K.

Biopharm Drug Dispos. 1983 Apr-Jun;4(2):113-24.

PMID:
6882880
27.

Lorazepam solubility in and sorption from intravenous admixture solutions.

Newton DW, Narducci WA, Leet WA, Ueda CT.

Am J Hosp Pharm. 1983 Mar;40(3):424-7.

PMID:
6133447
28.

Pharmacokinetic evaluation of the blood-to-lymph transfer of cyclosporin A in rats.

Ueda CT, Lemaire M, Misslin P.

Biopharm Drug Dispos. 1983 Jan-Mar;4(1):83-94.

PMID:
6839005
29.

Compatibility of lithium citrate syrup with 10 neuroleptic solutions.

Theesen KA, Wilson JE, Newton DW, Ueda CT.

Am J Hosp Pharm. 1981 Nov;38(11):1750-3.

PMID:
6118064
30.

Bioavailability of quinidine in congestive heart failure.

Ueda CT, Dzindzio BS.

Br J Clin Pharmacol. 1981 Jun;11(6):571-7.

31.

Preliminary observations on the absorption of liposome-encapsulated drug by the intestinal lymphatics.

Ueda CT, Nickols JG, Schmelter RF.

Res Commun Chem Pathol Pharmacol. 1981 Jun;32(3):487-98.

PMID:
7268193
32.

The effects of erythromycin on the absorption and disposition of kinetics of theophylline.

Branigan TA, Robbins RA, Cady WJ, Nickols JG, Ueda CT.

Eur J Clin Pharmacol. 1981;21(2):115-20.

PMID:
7341279
33.

Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits.

Ueda CT, Nickols JG.

J Pharm Sci. 1980 Dec;69(12):1400-3.

PMID:
7463324
34.

Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.

Ueda CT.

Biochem Pharmacol. 1980 Mar 1;29(5):737-40.

PMID:
20227949
35.

In vitro and in vivo characteristics of some commercial phenobarbital tablets.

Sylvestri MF, Ueda CT.

Int J Clin Pharmacol Biopharm. 1979 Dec;17(12):492-7.

PMID:
528095
36.
37.

Quinidine and dihydroquinidine interactions in human plasma.

Ueda CT, Makoid MC.

J Pharm Sci. 1979 Apr;68(4):448-50.

PMID:
438966
38.

Apparent stability of nitroglycerin in dextrose 5% in water.

Ludwig DJ, Ueda CT.

Am J Hosp Pharm. 1978 May;35(5):541-4.

PMID:
418679
39.

Quinidine kinetics in congestive heart failure.

Ueda CT, Dzindzio BS.

Clin Pharmacol Ther. 1978 Feb;23(2):158-64. No abstract available.

PMID:
620475
40.

Clinical and electrophysiological effects of intravenous quinidine in man.

Hirschfeld DS, Ueda CT, Rowland M, Scheinman MM.

Br Heart J. 1977 Mar;39(3):309-16.

41.

Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.

Ueda CT, Ballard B, Rowland M.

J Pharmacol Exp Ther. 1977 Mar;200(3):459-68.

PMID:
403278
42.

Absolute quinidine bioavailability.

Ueda CT, Williamson BJ, Dzindzio BS.

Clin Pharmacol Ther. 1976 Sep;20(3):260-5.

PMID:
954347
43.

Disposition kinetics of dihydroquinidine following quinidine administration.

Ueda CT, Williamson BJ, Dzindzio BS.

Res Commun Chem Pathol Pharmacol. 1976 Jun;14(2):215-25.

PMID:
940955
44.

Novel method for the determination of pediatric dosages.

Gill MA, Ueda CT.

Am J Hosp Pharm. 1976 Apr;33(4):389-92.

PMID:
1266880
45.

Disposition kinetics of quinidine.

Ueda CT, Hirschfeld DS, Scheinman MM, Rowland M, Williamson BJ, Dzindzio BS.

Clin Pharmacol Ther. 1976 Jan;19(1):30-6.

PMID:
1245091

Supplemental Content

Support Center